Global Bio-chem Technology Group Company Limited
GBCMY · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $4 | $4 | $4 | $5 |
| Enterprise Value | $4 | $4 | $5 | $7 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 7.6% | 22.7% | 26.3% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 13.6% | 13.8% | 7.3% | 11.5% |
| EBITDA | $0 | $0 | $0 | $4 |
| % Margin | 4.8% | 4.3% | 11.3% | 604.1% |
| Net Income | -$0 | $1 | -$0 | $4 |
| % Margin | -13% | 84.1% | -17.6% | 602.9% |
| EPS Diluted | -0.87 | 5 | -0.88 | 24 |
| % Growth | -117.4% | 668.2% | -103.7% | – |
| Operating Cash Flow | $0 | $0 | -$0 | $0 |
| Capital Expenditures | -$0 | $0 | $0 | -$0 |
| Free Cash Flow | $0 | $0 | -$0 | $0 |